Attached files

file filename
EX-32 - EXHIBIT 32 - PERRIGO Co plccy16q210qex32.htm
EX-31.2 - EXHIBIT 31.2 - PERRIGO Co plccy16q210qex312.htm
EX-31.1 - EXHIBIT 31.1 - PERRIGO Co plccy16q210qex311.htm
EX-10.12 - EXHIBIT 10.12 - PERRIGO Co plccy16q210qex1012.htm
10-Q - 10-Q - PERRIGO Co plccy16q210q.htm


Exhibit 10.8

May 23, 2016                            

Omega Pharma N.V.
IZ De Prijkels Venecoweg 269
B-9810 Nazareth
Belgium


Re:
Waiver to Note Purchase Agreement


Ladies and Gentlemen:
    
Reference is hereby made to that Waiver to Note Purchase Agreement dated as of May 16, 2016 between Omega Pharma N.V. (the “Company”) and each of the Noteholders party thereto, as the same may be amended, restated, modified or supplemented from time to time (as amended, the "Waiver"). Capitalized terms which are used herein without definition and which are defined in the Waiver shall have the same meanings herein as in the Waiver.
The Company has requested that the Noteholders amend the Waiver, and this letter is to confirm that the Company and the Noteholders have agreed to amend the Waiver by deleting the first and third of the three references to the date “May 25, 2016” in the Waiver, and replacing each of those two references in the Waiver with the date “June 8, 2016” so long as (a) each of the Subsidiary Guarantors has executed and delivered to the Noteholders the Subsidiary Guarantor Acknowledgment in the form of Exhibit B attached to the Waiver and (b) each of the Subsidiary Guarantors shall have executed this letter.
Except as expressly amended by this letter, all terms, conditions and covenants contained in the Waiver are hereby ratified and shall be and remain in full force and effect.
This letter shall become effective upon the execution and delivery hereof by the Company and the Noteholders. This letter supersedes any and all of our prior communications among the parties hereto, if any, regarding the subject of this letter.
THIS LETTER SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE LAW OF THE STATE OF NEW YORK EXCLUDING CHOICE-OF-LAW PRINCIPLES OF THE LAW OF SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE.

This letter may be executed in any number of counterparts, but all such counterparts shall together constitute but one instrument. Execution of this letter by any of the parties may be evidenced by way of a faxed transmission of such party’s signature and such faxed signature shall be deemed to constitute the original signature of such party to this letter.

    





If the foregoing is in accordance with your understanding, please confirm your agreement to the amendment set forth herein by signing this letter in the space indicated below.
                
Very Truly Yours,
 
 
THE PRUDENTIAL INSURANCE COMPANY OF
AMERICA
 
 
BY:
/s/ Joshua Shipley
 
Name: Joshua Shipley
 
Title: Vice President
 
 


Accepted and Agreed:

OMEGA PHARMA N.V.
By:
/s/ John T. Hendrickson
 
Name: John T. Hendrickson
 
Title: Chief Executive Officer
 
 
 
 
By:
/s/ Judy L. Brown
 
Name: Judy L. Brown
 
Title: Executive Vice President, Business Operations and Chief Financial Officer
 
 

OMEGA PHARMA BELGIUM N.V.
By:
/s/ Excito BVBA
 
Name: Excito BVBA
 
Title: Director
 
 
By:
/s/ Brandracer BVBA
 
Name: Brandracer BVBA
 
Title: Director

CHEFARO NEDERLAND B.V. (CURRENTLY OMEGA PHARMA NEDERLAND BV)
By:
/s/ Brandracer BVBA
 
Name: Brandracer BVBA
 
Title: Director





OMEGA PHARMA HOLDING NEDERLAND B.V.
By:
/s/ Joost Hunfeld
 
Name: Joost Hunfeld
 
Title: Director

OMEGA PHARMA ESPAÑA S.A.
By:
/s/ Brandracer BVBA
 
Name: Brandracer BVBA
 
Title: Director

CHEFARO PHARMA ITALIA SRL
By:
/s/ Geert Cools
 
Name: Geert Cools
 
Title: Director

ACO HUD AB (CURRENTLY OMEGA PHARMA NORDIC AB)
By:
/s/ Geert Cools
 
Name: Geert Cools
 
Title: Director
 
 
By:
/s/ Magnus Bruhn
 
Name: Magnus Bruhn
 
Title: Director

DEUTSCHE CHEFARO GMBH (CURRENTLY OMEGA PHARMA DEUTSHLAND GmBH)
By:
/s/ Stephan Tomat
 
Name: Stephan Tomat
 
Title: Director





WARTNER EUROPE B.V.
By:
/s/ Brandracer BVBA
 
Name: Brandracer BVBA
 
Title: Director

DAMIANUS B.V.
By:
/s/ Calisco BVBA
 
Name: Calisco BVBA
 
Title: Director

MEDGENIX BENELUX N.V.
By:
/s/ Excito BVBA
 
Name: Excito BVBA
 
Title: Director
 
 
By:
/s/ Brandracer BVBA
 
Name: Brandracer BVBA
 
Title: Director

BIOVER NV
By:
/s/ Calisco BVBA
 
Name: Calisco BVBA
 
Title: Director
 
 
By:
/s/ Pachterbos BVBA
 
Name: Pachterbos BVBA
 
Title: Director

ACO HUD NORDIC AB
By:
/s/ Geert Cools
 
Name: Geert Cools
 
Title: Director
 
 
By:
/s/ Magnus Bruhn
 
Name: Magnus Bruhn
 
Title: Director






RICHARD BITTNER AG
By:
/s/ Magnus Bruhn
 
Name: Magnus Bruhn
 
Title: Director